{"id":"W2138501761","doi":"10.1158/1078-0432.ccr-03-0463","title":"Phase II Study of Celecoxib and Trastuzumab in Metastatic Breast Cancer Patients Who Have Progressed after Prior Trastuzumab-Based Treatments","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Trastuzumab; Medicine; Metastatic breast cancer; Celecoxib; Breast cancer; Internal medicine; Oncology; Regimen; Rash; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002698268,0.0004202937,0.00136976,0.0007057408,0.0002157738,0.00005868447,0.0004021233,0.00021158,0.0008149935],"category_scores_gemma":[0.0005454462,0.0003375211,0.000196069,0.001251952,0.001015381,0.0001660839,0.0002720054,0.001616374,0.000009928872],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00199257,"about_ca_system_score_gemma":0.003763655,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00685728,"about_ca_topic_score_gemma":0.007446992,"domain_scores_codex":[0.9922078,0.001023021,0.001593751,0.001280095,0.002579052,0.001316276],"domain_scores_gemma":[0.9963981,0.0006548248,0.0002143289,0.000782755,0.001123575,0.0008264455],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01841379,0.06630662,0.7325349,0.000696503,0.0004787645,0.0004057983,0.002416289,0.00003905829,0.0001175238,0.000002365635,0.0003404721,0.1782479],"study_design_scores_gemma":[0.1085104,0.04603155,0.8404961,0.001509889,0.0002602902,0.000005733517,0.0009079091,0.000408015,0.001152619,0.00006098922,0.0003147758,0.0003416871],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989969,0.00141669,0.00000407746,0.001470724,0.0001175875,0.006370603,0.0005236071,0.00002861287,0.00009910311],"genre_scores_gemma":[0.9938066,0.0006120263,0.0001362436,0.0001528344,0.0001710115,0.004655345,0.00002688939,0.0001039945,0.000335043],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1779062,"threshold_uncertainty_score":0.9999077,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1846703249882754,"score_gpt":0.5588671635938909,"score_spread":0.3741968386056155,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}